Riskpilot← Back to searchSign inGet full accessHaga vårdkonsult AB
ABActiveOrg 5591908230Hagagatan 16 Lgh 1302Medical specialists activities · NACE 8622Est. 20192 employees
Revenue 2025
SEK 1,1M
-19% vs 2024
EBITDA margin
31.3%
+15% vs 2024
Equity ratio
54.8%
Financial strength
Net profit 2025
SEK 295K
+25% vs 2024
| Revenue | SEK 1,1M | -19% |
| EBITDA | SEK 339K | +15% |
| Net profit | SEK 295K | +25% |
| Total assets | SEK 671K | -5% |
| Equity | SEK 368K | -1% |
| Employees | 2 | — |
Legal name
Haga vårdkonsult AB
Org number
5591908230
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 januari 2019
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva sjuk- och hälsovård dels som underleverantör till andra sjukvårdsbolag och dels direkt av landstinget samt därmed förenlig verksamhet.
Address
Hagagatan 16 Lgh 1302
Email
drnilsson@hotmail.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 457 | 368 | 1 606 | 1 343 | 1 082 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 283 | 169 | 454 | 296 | 339 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 283 | 169 | 454 | 296 | 339 |
| Net financials | — | — | — | 7 | 4 |
| Profit before tax | 210 | 125 | 393 | 303 | 375 |
| Tax | −45 | −27 | −91 | −67 | −80 |
| Net profit | 165 | 98 | 302 | 236 | 295 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 397 | 450 | 811 | 704 | 671 |
| Equity | 237 | 235 | 437 | 373 | 368 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 56 | 67 | 166 | 122 | 126 |
| Total debt | 56 | 67 | 166 | 122 | 126 |
EBITDA margin
31.3%
This company
15.8%
Market median
+98% vs market
20212025
Equity ratio
54.8%
This company
38.2%
Market median
+43% vs market
20212025
Return on equity
80.2%
This company
18.4%
Market median
+336% vs market
20212025
Net profit margin
27.3%
This company
8.1%
Market median
+237% vs market
20212025
Asset turnover
1.61×
This company
1.12×
Market median
+44% vs market
20212025
Debt / equity
0.82×
This company
0.62×
Market median
+32% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LH Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Haga vårdkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Håkan Nilsson | Chief Executive Officer | 0 companies |
| Ann-Christine Margareta Nilsson | Deputy Board Member | 0 companies |